DEA highlights cannabis’s medical benefits & relative safety in rescheduling hearing (Newsletter: June 30, 2026)
The DEA presented evidence regarding cannabis's medical benefits and relative safety during a rescheduling hearing, while bipartisan lawmakers indicated that opposition to rescheduling faces political obstacles. The hearing drew marijuana reform advocates and included discussion of related legal matters including cannabis and Second Amendment rights, plus state-level legalization developments.
Filed under Federal Action in THC Minnesota's coverage of Minnesota's cannabis and hemp market.
Mentioned
Source Attribution
This summary was compiled from information published by Marijuana Moment. All facts and statements reflect the original source material. For complete details, refer to the original publication.
View Original Source →Related Updates
DEA Will Highlight Testimony On Marijuana’s Medical Benefits In Rescheduling Hearing, New Filing Shows
Feds sued over Medicare cannabis product coverage (Newsletter: April 1, 2026)
Trump puts medical cannabis protections in budget (Newsletter: April 6, 2026)
Marijuana Rescheduling Appeal Process ‘Remains Pending’ Despite Trump’s Executive Order, DEA Says In New Filing
Marijuana Rescheduling Could ‘Unlock Research’ To Treat Rare Diseases, Father Of Terminally Ill Child Tells Congressional Committee
Anti-Marijuana Groups File Lawsuit To Block Trump Administration’s Hemp CBD And THC Medicare Coverage Plan
Stay current on Minnesota cannabis
Browse more federal action updates, the full news feed, or the Minnesota cannabis timeline. Compare products across licensed dispensaries and read our consumer guides.